These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7625623)

  • 21. Long-term outcome of postremission chemotherapy for adults with acute myeloid leukemia using different dose-intensities.
    Jehn U
    Leuk Lymphoma; 1994 Sep; 15(1-2):99-112. PubMed ID: 7532060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. De novo and secondary acute myeloid leukemia in patients over the age of 65: a review of fifty-six successive and unselected cases from a general hospital.
    Bauduer F; Ducout L; Dastugue N; Capdupuy C; Renoux M
    Leuk Lymphoma; 1999 Oct; 35(3-4):289-96. PubMed ID: 10706452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Remission induction therapy of untreated acute myeloid leukemia using a non-cytarabine-containing regimen of idarubicin, etoposide, and carboplatin.
    Bow EJ; Gallant G; Williams GJ; Woloschuk D; Shore TB; Rubinger M; Schacter BA
    Cancer; 1998 Oct; 83(7):1344-54. PubMed ID: 9762935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Acute myeloid leukemia in those over 70 years of age. Experience using low-dose ara-C treatment].
    Rodríguez JN; Fernández-Jurado A; Martino ML; Diéguez JC; Moreno MV; Quesada JA; Polo B; Cañavate M; Amian A; Prados D
    Sangre (Barc); 1998 Feb; 43(1):35-9. PubMed ID: 9580427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
    Löwenberg B; Suciu S; Archimbaud E; Haak H; Stryckmans P; de Cataldo R; Dekker AW; Berneman ZN; Thyss A; van der Lelie J; Sonneveld P; Visani G; Fillet G; Hayat M; Hagemeijer A; Solbu G; Zittoun R
    J Clin Oncol; 1998 Mar; 16(3):872-81. PubMed ID: 9508168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival.
    Ertz-Archambault N; Kosiorek H; Slack JL; Lonzo ML; Greipp PT; Khera N; Kelemen K
    Biol Blood Marrow Transplant; 2017 May; 23(5):782-789. PubMed ID: 28189903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Granulocytic sarcoma (chloroma) in ophthalmology].
    Dhermy P
    J Fr Ophtalmol; 1982; 5(12):779-86. PubMed ID: 6963287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Postremission therapy with low-dose interleukin 2 with or without intermediate pulse dose interleukin 2 therapy is well tolerated in elderly patients with acute myeloid leukemia: Cancer and Leukemia Group B study 9420.
    Farag SS; George SL; Lee EJ; Baer M; Dodge RK; Becknell B; Fehniger TA; Silverman LR; Crawford J; Bloomfield CD; Larson RA; Schiffer CA; Caligiuri MA
    Clin Cancer Res; 2002 Sep; 8(9):2812-9. PubMed ID: 12231521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interleukin-2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 cases.
    Meloni G; Vignetti M; Andrizzi C; Capria S; Foa R; Mandelli F
    Leuk Lymphoma; 1996 May; 21(5-6):429-35. PubMed ID: 9172807
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive chemotherapy with mitoxantrone administered as a single injection in patients with high-risk acute myeloid leukemia: results of the EMA 2000 trial.
    Thomas X; Elhamri M; Chelghoum Y; Reman O; Arnaud P; Raffoux E; Le QH; Tavernier E; Dombret H; Michallet M
    Ann Hematol; 2005 Jun; 84(6):376-82. PubMed ID: 15782343
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chloroma--a rare symptom of acute leukemia].
    Deptała A; Paluszewska M; Maryniak R; Rymkiewicz K
    Pol Tyg Lek; 1994 Mar 21-28; 49(12-13):291-3. PubMed ID: 7808956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intensive postremission chemotherapy in adults with acute myeloid leukemia. Cancer and Leukemia Group B.
    Mayer RJ; Davis RB; Schiffer CA; Berg DT; Powell BL; Schulman P; Omura GA; Moore JO; McIntyre OR; Frei E
    N Engl J Med; 1994 Oct; 331(14):896-903. PubMed ID: 8078551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benefit of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia.
    Schiller G; Gajewski J; Lee M; Ho W; Territo M; Champlin R
    Leuk Lymphoma; 1994 Sep; 15(1-2):85-90. PubMed ID: 7858506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of survival. Chemotherapeutically treated and untreated older patient with acute myeloid leukemia.
    Siddiqui T; Durkin WJ; Conley NS; Doughney KB; Favis GR; Weiss R; Smith AE
    J Fla Med Assoc; 1994 Jul; 81(7):475-7. PubMed ID: 7964574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autologous bone marrow transplantation versus intensive consolidation chemotherapy for acute myeloid leukemia in childhood. Pediatric Oncology Group.
    Ravindranath Y; Yeager AM; Chang MN; Steuber CP; Krischer J; Graham-Pole J; Carroll A; Inoue S; Camitta B; Weinstein HJ
    N Engl J Med; 1996 May; 334(22):1428-34. PubMed ID: 8618581
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute leukemia in adults: comparison of survival between a treated and an untreated group.
    Noon MA; Hess CE
    South Med J; 1976 Sep; 69(9):1157-60. PubMed ID: 1067671
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival of elderly patients with acute myeloid leukemia.
    Pulsoni A; Pagano L; Latagliata R; Casini M; Cerri R; Crugnola M; De Paoli L; Di Bona E; Invernizzi R; Marmont F; Petti MC; Rigolin G; Ronco F; Spadano A; Tosti ME; Visani G; Mele A; Mandelli F
    Haematologica; 2004 Mar; 89(3):296-302. PubMed ID: 15020267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A phase I/II study of oral etoposide and idarubicin in elderly patients with high-risk acute myeloid leukemia unable to undergo intensive chemotherapy.
    Fiegl M; Büchner T; Hiddemann W; Braess J
    Ann Hematol; 2005 Apr; 84(4):227-31. PubMed ID: 15517268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy of acute myeloid leukemia in children.
    Nesbit ME; Woods WG
    Leukemia; 1992; 6 Suppl 2():31-5. PubMed ID: 1578938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High survival rate in infant acute leukemia treated with early high-dose chemotherapy and stem-cell support. Groupo Español de Trasplante de Médula Osea en Niños.
    Marco F; Bureo E; Ortega JJ; Badell I; Verdaguer A; Martínez A; Muñoz A; Madero L; Olivé T; Cubells J; Castel V; Sastre A; Maldonado MS; Díaz MA
    J Clin Oncol; 2000 Sep; 18(18):3256-61. PubMed ID: 10986058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.